Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Krystal Biotech (KRYS) Return on Sales (2021 - 2025)

Krystal Biotech (KRYS) has disclosed Return on Sales for 4 consecutive years, with 0.48% as the latest value for Q4 2025.

  • Quarterly Return on Sales fell 2.0% to 0.48% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.53% through Dec 2025, up 22.0% year-over-year, with the annual reading at 0.53% for FY2025, 22.0% up from the prior year.
  • Return on Sales hit 0.48% in Q4 2025 for Krystal Biotech, down from 0.81% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 46.63% in Q4 2021 to a low of 0.02% in Q1 2024.
  • Historically, Return on Sales has averaged 5.84% across 4 years, with a median of 0.44% in 2025.
  • Biggest five-year swings in Return on Sales: plummeted -911bps in 2024 and later skyrocketed 49bps in 2025.
  • Year by year, Return on Sales stood at 46.63% in 2021, then crashed by -100bps to 0.21% in 2023, then surged by 142bps to 0.5% in 2024, then dropped by -4bps to 0.48% in 2025.
  • Business Quant data shows Return on Sales for KRYS at 0.48% in Q4 2025, 0.81% in Q3 2025, and 0.4% in Q2 2025.